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Abstract
Background: The cardiac resynchronization therapy (CRT) is an effective option for patients with advanced heart failure 
(HF). Clinical, electrocardiographic and echocardiographic criteria have been studied in an attempt to find the patients 
that will benefit from the CRT, considering that the echocardiogram is the method that is used both in the selection and 
in the assessment of such therapy. 
Objective: The objective of this work is to analyze the use of echocardiogram to assess the CRT, in a ten-day follow-up 
period and after two years of evolution.
Method: The assessment considered 0 patients subjected to CRT, for a period of two years, 80% of which were male. 
The Minnesota Living with Heart Failure Questionnaire (MLWHF) was filled out. Patients underwent a six-minute walking 
test. Then, the two-dimensional echo-Doppler-cardiogram was performed. The initial assessment was repeated ten days 
after and two year after the implantation of the biventricular pacemaker.  
Results: In two years, 5 patients (5%) died; 4 had cardiomyopathy caused by the Chagas’s disease. There was no 
statistically significant change in the ejection fraction between the pre-operation period and the following ten days, but 
there was a significant change between the pre-operation period and two years after that, and the ten-day period and 
two years after that. In the ten-day follow-up period, there was the worsening of the intraventricular dyssynchrony, as 
evaluated by the tissue Doppler method, and the “living with heart failure” score was higher in the group of deaths.
Conclusion: Out of the echocardiographic parameters assessed, only the intraventricular dyssynchrony assessment 
through the tissue Doppler method, after the procedure, was capable of predict the CRT efficiency with respect to the 
death rate. (Arq Bras Cardiol 00; 94() : -8)
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Introduction
Heart failure (HF) is a medical condition with a high 
morbidity-mortality rate that affects approximately 23 million 
people in the world1. According to DATASUS2, in Brazil, in 
the period between January and July 2008, 147,348 hospital 
admissions caused by HF.
Intraventricular conduction disturbances with extension 
of the QRS complex are present in 25-50% of HF patients3-
6, in which the most frequent case is the left bundle branch 
block (LBBB)6,7.
The conduction of the electrical stimulus is associated with 
the functional cardiac efficiency. In patients in whom there is 
a change in the regular conduction of the stimulus, there may 
be some interference in the ventricular and/or atrial contractile 
coordination – called cardiac dyssynchrony. That may cause 
a change in the myocardial function8,9. 
Cazeau et al10, in 1994, described the stimulation of the 
left ventricle through the coronary sinus, with a four-chamber 
pacemaker.  In 2001, the cardiac resynchronization therapy 
(CRT) was approved for clinical use by the Food and Drug 
Administration (FDA). After that, more than 270,000 patients 
have already undergone the procedure11. In Brazil, according 
to Pachón et al12, in the period from 1994 to 2006, 2,180 
resynchronizers were implanted. Nowadays, the CRT, through 
heart stimulation with a biventricular pacemaker, has been 
used as an auxiliary therapy in patients that are refractory to 
optimized medication therapy13,14.
Bakker et al15, in an analysis of 5 patients with dilated 
cardiomyopathy, with large QRS and who were refractory 
to medication, were the first authors to demonstrate the 
correlation between biventricular stimulation and the 
improvement in heart performance. After that, many 
studies were published to assess the effects of biventricular 
stimulation16-18.
Despite the proven benefits of CRT16-18, approximately 
20-30% of patients do not respond to this therapy (they are 
called “non-responders”19,20). That makes it necessary to adopt 
additional selection criteria to identify patients that will benefit 
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from cardiac resynchronization21,22.
According to the Brazilian Guidelines for Implantable 
Electronic Cardiac Devices (2007)23, recommendation I and 
the evidence level A for CRT is: Patients in functional class III 
or IV (NYHA), with optimized medication therapy, ejection 
fraction ≤ 35%, sinus rhythm and duration of the QRS 
complex > 150 ms or QRS between 120 and 150 ms, with 
proof of dyssynchrony by the imaging method.
The use of echocardiography as a supplemental method 
for indication of the CRT was described for the first time in 
2005, in the CARE-HF (Cardiac Resynchronization - Heart 
Failure)24 study, which compared the effect of CRT on the 
risk of complications and death. Countless echocardiographic 
techniques have been proposed to quantify the ventricular 
dyssynchrony, with the purpose of optimizing the selection 
of patients for the CRT25. 
Pitzalis et al26 used the monodimensional mode (M mode) 
to assess the intraventricular dyssynchrony, considering 
values above 130 ms as abnormal. The pulsed Doppler is an 
echocardiographic method used to assess the intraventricular 
dyssynchrony24, by the electromechanical delay difference 
between the right and left ventricles, indicating dyssynchrony 
when the values above 40 ms19,25. 
The echocardiogram is also used in the evaluation of the 
mitral regurgitation. Breithardt et al27 studied its acute effects 
on CRT, assessing 24 patients subjected to resynchronization, 
who did not show significant reduction in the level of mitral 
insufficiency, directly associated with the dP/dt increase.
The tissue Doppler allows identifying and measuring the 
myocardial motion speed, by positioning the cursor in the 
segment that you wish to evaluate28. Bax et al19, in a study 
with 85 patients for a 6-month follow-up period after the CRT, 
demonstrated, among four basal segments, sensitiveness and 
specificity of 80% as predictor of clinical improvement and 92% as 
predictor of reverse modeling, in the presence of interval greater 
than 65 ms and evaluated by the tissue Doppler.
Objective
The objective of this work is to analyze the use of 
the echocardiogram in the evaluation of the cardiac 
resynchronization therapy, in patients with refractory HF, in 
a short follow-up period (ten days) and after two years of 
evolution.
Case selection and method
The study was based on 20 patients, to whom a 
biventricular pacemaker implant had been prescribed, 
through the coronary sinus, for cardiac resynchronization 
therapy, aged 59.70 ± 12.59 years on average, 16 of 
which (80%) were male, monitored for a two-year period. 
The cardiomyopathy had been caused by ischemia in 10 
patients (50%), by Chagas’s disease in 6 patients (30%) 
and by other unknown factors in 4 patients (20%). Fifteen 
patients (75%) were in functional class III and 5 (25%) in 
functional class IV, when the resynchronization therapy was 
prescribed to them. 
Study dynamics
When the CRT was prescribed, the patients’ medical 
history was prepared. Then, they underwent clinical tests 
and were classified according to the New York Heart 
Association (NYHA), for a functional evaluation. After the 
initial clinical evaluation, the Minnesota Living with Heart 
Failure Questionnaire (MLWHFQ) was filled out. The 
distance traveled was determined (in meters, through a 
six-minute walking test) and the two-dimensional echo-
Doppler-cardiogram was performed, with the use of a 3.5 
Hz transducer in the Nemio equipment (Toshiba). Ten days 
after the biventricular pacemaker was implanted, the entire 
initial evaluation was repeated, and the same process was 
repeated after two years.
Echocardiographic evaluation
Evaluation of the left ventricular function
The ejection fraction of the left ventricle was evaluated 
through the two-dimensional method (Simpson’s method). 
In addition, the myocardial performance index (or Tei index) 
was calculated, for evaluating the systole and diastole functions 
of the left ventricle, calculated by the sum of isovolumetric 
contraction and relaxation times divided by the ejection time, 
considering values below 0.40 as normal. 
Evaluation of the reverse remodeling
The reverse remodeling is characterized by a reduction 
of more than 15% of the final systolic volume, evaluated by 
the echocardiogram, between the pre-operation and post-
operation periods.
Evaluation of the mitral regurgitation
The mitral regurgitation evaluation was conducted with the 
use of the color flow mapping in the four-chamber apical and 
parasternal cross-section slices. The mitral regurgitation was 
quantified by the ratio of the regurgitating jet area to the left 
atrium area, considering that the regurgitation is minor when 
the percentage area is smaller than 20% and important when 
it is larger than 40%.
Evaluation of the interventricular dyssynchrony
The pulsed Doppler method was used to analyze the 
interventricular dyssynchrony, through the electromechanical 
delay difference between left and right ventricles, by measuring 
the time interval between the R wave of the electrocardiogram 
and the beginning of the speed curve of the aortic flow and 
pulmonary flow. Interval above 40 ms indicates interventricular 
dyssynchrony.
Evaluation of the intraventricular dyssynchrony
The M-mode and the tissue-Doppler methods were used 
to assess the intraventricular dyssynchrony. In the short-axis 
parasternal slice, at the level of the papillary muscles, the 
M-mode evaluation was performed, by measuring the time 
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Table 1 - Mean and standard deviation in the comparison of clinical, electrocardiographic and echocardiographic variables throughout time
Variable
Pre-operation 10 days Two years
p-value*
Mean ± S.D. Mean ± S.D. Mean ± S.D.
FC 3.25 ± 0.44 2.65 ± 0.67 2.47 ± 0.51 <0.001
LWHF 66.70 ± 14.39 39.40 ± 16.76 53.73 ± 15.42 <0.001
6min 234.50 ± 110.09 248.50 ± 106.91 257.33 ± 90.59 0.182
QRS 154.5 ± 18.48 129.00 ± 22.91 134.00 ± 24.14 <0.001
EJ 27.90 ± 5.51 29.80 ± 6.90 31.67 ± 4.98 0.030
INTER 41.90 ± 22.21 18.30 ± 21.62 28.40 ± 16.58 <0.001
S/PW 185.90 ± 95.21 108.20 ± 139.89 125.93 ± 95.08 0.025
MPI 1.37 ± 0.61 1.33 ± 0.72 1.31 ± 0.41 0.396
FDV 420.50 ± 125.91 412.60 ± 124.74 414.40 ± 126.33 0.129
FSV 179.00 ± 81.20 187.60 ± 84.92 177.47 ± 70.48 0.382
LVDD 73.85 ± 6.83 72.85 ± 6.49 73.93 ± 6.14 0.039
Tissular 76.10 ± 11.10 49.50 ± 25.15 53.47 ± 19.31 <0.001
FC – functional class; LWHF – living with heart failure score; 6 min – distance traveled in the six-minute walking test; QRS – QRS complex time length; EF – ejection 
fraction; INTER – interventricular dyssynchrony; S/PW – time between the maximum contraction of the septum and the posterior wall; MPI – myocardial performance 
index; FDV – final diastolic volume; FSV – final systolic volume; LVDD – left ventricle diastolic diameter; Tissular – use of tissue-Doppler to assess the intraventricular 
dyssynchrony.
interval between the maximum contraction of the septum 
and the posterior wall of the left ventricle (S/PW), considering 
as dyssynchrony values above 130 ms. In the tissue-Doppler 
evaluation, the myocardial speeds are obtained in the apical 
plane of the basal segments of septal, lateral, anterior and 
inferior walls, and the time interval between the beginning 
of the QRS complex and the peak of the myocardial systolic 
wave of the tissue-Doppler is measured in the different 
segments. There is significant dyssynchrony when the time 
interval difference is higher than 65 ms between any segments 
assessed. The values considered were obtained by the average 
of four consecutive heart beats.
Statistical analysis
The Statistical Package for Social Sciences (SPSS) for 
Windows, version 11.5, was used for analyzing the data. To 
run the tests, bilateral hypotheses and a significance level α = 
5% were taken into account. Descriptive statistics were used 
to assess the frequency, average and standard deviation of 
the variables of interest. The t-test for independent samples 
was used for the comparison of the age-variable averages. 
The Mann-Whitney test was used to analyze clinical, 
electrocardiographic and echocardiographic variables, when 
they were quantitative variables. 
The Chi-square test was used to check if the proportions 
of the categories of clinical and echocardiographic variables, 
when they were qualitative variables, were homogenous in 
groups of interest. For comparing the functional class, “living 
with heart failure” score and traveled distance, QRS time 
length variables and echocardiographic variables (ejection 
fraction, mitral insufficiency, interventricular dyssynchrony, 
posterior wall/septum distance, myocardial performance 
index, final diastolic and systolic volume, diastolic diameter of 
the left ventricle and tissue-Doppler throughout time [before 
operation, 10 days and two years]), the NON-PARAMETRIC 
ANOVA (Analysis of Variance) was used.
Results
In this work, 20 patients in whom a biventricular pacemaker 
was implanted were monitored for two years. There were 
neither complications with respect to the surgical procedure 
nor deaths in the 10-day follow-up period after operation.
An analysis was conducted to assess the behavior of 
clinical, electrocardiographic and echocardiographic variables, 
comparing them in the period before and after the operation 
(10 days after and two days after). When the pacemaker 
was implanted, 15 patients were in functional class III; 5 in 
functional class IV; 13 patients (65%) showed improvement 
in the functional class in the first post-operation evaluation; 
6 (30%) kept the same functional class; and there was 
worsening of the functional class in one patient (5%). In the 
two-year follow-up period, 10 patients showed no change 
in the functional class, compared to the previous evaluation, 
and there was improvement in three patients and worsening 
in two of them.
In the assessment of variables throughout time, it was 
possible to find statistically significant differences for the 
following variables: functional class, living with heart failure 
score, QRX complex time length, ejection fraction, inter and 
intraventricular dyssynchrony (time between contraction of 
septum and the posterior wall – M mode and tissue-Doppler) 
and diastolic diameter of left ventricle. Table 1 shows the mean 
and the standard deviation for each one of the variables in 
the pre-operation period, in the 10 days after the surgery and 
two years after the CRT.
The average time length of the QRS complex in the pre-
operation period was 154.5 ± 18.48 ms; 129.0 ± 22.91 ms 
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Table 2 - Mean, standard deviation and p-value referring to the 
comparison of the means of the functional class variable in the 
groups of interest in the pre-operation periods, 10 days after and 
two years after surgery
Variables
QRS ≤ 160 QRS > 160
p-value
Mean ± S.D Mean ± S.D
FC pre-operation 3.07 ± 0.26 3.67 ± 0.51 0.006
FC 10 days 2.67 ± 0.69 2.50 ± 0.71 0.853
FC two years 2.43 ± 0.41 3.00 ± 0.0 -
FC – functional class; S.D. - standard deviation.
Chart 1 - Use of tissue-Doppler to evaluate the intraventricular dyssynchrony in pre-operation period, after ten days and in the two-year follow-up period (p < 0,001).
in the 10-day evaluation; and 134.0 ± 24.14 ms in the two-
year evaluation, with p < 0,001. 
When the QRS complex time length and functional class 
were compared, it was possible to notice that patients with 
QRS time length, showed a higher functional class, in the 
pre-operation evaluation (p = 0.006), but there was not 
statistically significant difference in the post-operation periods 
(Table 2).
For the functional class, QRX complex time length and 
tissue-Doppler variables, it was possible to notice statistically 
significant differences between the pre-operation period 
and the evaluation 10 days after the procedure, as well as 
between the pre-operation period and two years after the 
post-implantation. However, there was no difference between 
the 10-day and two-year periods. For these variables, it was 
possible to see a reduction in the measures after the surgical 
intervention, which remained stable after two years. In Chart 
1, it is possible to analyze the variation noticed throughout 
time by the evaluation of the tissue-Doppler.
For the ejection fraction, we noticed no statistically 
significant difference between the pre-operation period and 
the ten days after the operation, but there were differences 
between the pre-operation period and the next two years and 
between the ten days and the two subsequent years. 
It was possible to find statistically significant differences 
between all periods in the assessment of the following 
variables: Interventricular dyssynchrony, posterior wall/septum 
distance and living with heart failure score. Therefore, there 
was a significant reduction when we compare the pre-
operation period and the 10 days after that and the pre-
operation period and the two subsequent years in the three 
variables analyzed. However, there was a statistically significant 
increase in the values found between the 10-day period and 
two-year period of these variables.
In the assessment of the LVDD, there was significant 
reduction between the pre-operation period and the 10-day 
period and significant increase between the 10-day period 
and the two-year period, so there is no statistically significant 
difference between initial and final measurements. 
In our case selection, 5 patients (25%) died. In Table 3, it is 
possible to see that the proportion of men in the death group 
to men in the non-death group is homogeneous (86.7% and 
60%, respectively), with predominance of men in both groups, 
and with no significant difference between the proportion of 
men to women in the two groups (p = 0.249). 
For the cause (etiology) variable, in the non-death group, 
the number of patients with dilated and ischemic etiology is 
larger than in the death-group. In Chagas-disease etiology, 
the situation is the opposite: 80% of patients are in the 
death group, and there is a statistically significant difference 
in the proportions of the etiology types according to death 
(p = 0.018).
 There was no statistically significant difference between 
the death and non-death groups for the mitral insufficiency 
variable and QRS complex time length variable, both in the 
pre-operation period and after 10 days. 
Table 4 shows the comparisons of the following variables: 
functional class, living with heart failure score, traveled 
distance, interventricular dyssynchrony, posterior wall/septum 
distance, myocardial performance index, final systolic and 
diastolic volume and tissue-Doppler in the pre-operation 
period and 10 days after surgery.
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Table 4 - Mean, standard deviation and p-value for the comparison of the averages of variables of interest, in death and non-death groups, in 




Mean ± S.D Mean ± S.D
Pre-operation
FC 3.20 ± 0.41 3.40 ± 0.54 0.553
EJ 27.20 ± 5.26 30.00 ± 6.32 0.266
INTER 43.13 ± 22.59 38.20 ± 23.11 0.612
S/PW 198.33 ± 105.11 148.60 ± 45.46 0.612
MPI 1.3607 ± 0.39 1.4260 ± 1.11 0.230
FDV 438.20 ± 136.83 367.40 ±71.24 0.349
FSV 183.73 ± 85.86 164.80 ± 71.97 0.866
LVDD 74.53 ± 7.49 71.80 ± 4.32 0.612
Tissular 76.13 ± 12.25 76.00 ± 7.71 1.000
LWHF 67.40 ± 15.44 64.60 ± 11.95 0.735
6 min 250.67 ±116.77 186.00 ± 77.00 0.230
10 days
FC 2.53 ± 0.51 3.00 ± 1.00 0.395
EJ 31.33 ± 6.29 25.20 ± 7.22 0.142
INTER 16.93 ± 20.58 22.40 ± 26.62 0.933
S/PW 109.47 ± 113.25 104.40 ± 219.20 0.349
MPI 1.2813 ± 0.53 1.4820 ±1.23 0.735
FDV 426.40 ±136.60 371.20 ± 75.77 0.612
FSV 197.40 ± 87.04 158.20 ± 79.35 0.497
LVDD 73.33 ± 7.03 71.40 ± 4.87 0.735
Tissular 39.20 ± 18.58 80.40 ± 14.31 0.002
LWHF 33.53 ± 12.23 57.00 ± 17.17 0.019
6 min 271.33 ± 106.09 180.00 ± 79.68 0.119
*Mann-Whitney. (FC – functional class; EF – ejection fraction; INTER – assessment of the interventricular dyssynchrony; S/PW – distance between the maximum 
contraction of the septum and the posterior wall; IPM – myocardial performance index; FDV – final diastolic volume; FSV – final systolic volume; LVDD – left ventricle 
diastolic diameter; Tissural – tissue-Doppler, LWHF – living with heart failure score; 6 min – distance traveled in the six-minute walking test).
Table 3 - Frequency and percentage of patients in the death group 
and non-death group, according to gender and cause (etiology)
Non-death Death p-
























There was no statistically significant difference between 
the death and non-death group, in the assessment of pre-
operation variables. However, in the 10-day assessment, 
there was a statistically significant difference in the living with 
heart failure score, and the living with heart failure score of 
death group patients is higher than that of non-death group 
patients.  The same thing happened for the tissue-Doppler 
variable, in which the values of the death group suggested 
greater intraventricular dyssynchrony. 
Discussion 
HF is a serious public health problem, with high morbidity-
mortality rate and costs above 33 billion dollars a year1. 
In around 25-50% of HF patients, there is the presence 
of intraventricular conduction disturbance, in which the left 
bundle branch block occurs more frequently. Baldasseroni 
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et al7, assessed, in 2002, the link between the LBBB and the 
mortality rate and demonstrated that LBBB is an unfavorable 
prognostic marker and regardless of age, HF level and use 
of therapy.  
Nowadays, the CRT has been used as an auxiliary therapy 
in patients that are refractory to optimized medication 
therapy16,18. 
In our case selection, we assessed 20 patients, 15 of which 
were in functional class III and 5 in functional class IV, who 
had undergone the CRT through the coronary sinus, and 
without complications inherent in the procedure. All patients 
show LBBB in the electrocardiogram, with QRS complex time 
length above 120 ms.
Despite the proven benefits of CRT16-18, approximately 
20-30% of patients do not respond to this therapy19,20. That 
makes it necessary to implement additional criteria to identify 
patients that will be entitled to this benefit21,22.
In this case selection, in the follow-up period of 10 days 
after implantation of the biventricular pacemaker, there was 
an improvement in the functional class in 13 patients (65%), 
worsening in one of them (5%) and in 6 patients (30%) the 
functional class remained unchanged. After two years of 
evolution, 8 patients were in functional class II and 7 in 
functional class III. The mortality in this period was of 25% 
(5 patients), with no correlation between the death and the 
worsening of the functional class. 
In the assessment of the causes of the cardiomyopathy, 
Reuter et al29 associated the dilated cardiomyopathy with 
the better clinical response of CRT. Martinelli Filho et al30, 
in a study including patients whose heart failure resulted 
from Chagas’s disease, there was a significant reduction in 
the functional class in patients with dilated cardiomyopathy, 
besides the fact that this etiology had been a predictor, 
regardless of clinical improvement.
Among the patients of this study, the ones whose 
cardiomyopathy had been caused by Chagas’s disease were 
linked to the higher death rate, with statistically significant 
when compared to patients with ischemic and dilated 
etiology. 
Shamim et al8 assessed, in a 36-month follow-up period, 
the association between the QRS duration and the mortality, 
where patients with QRS below 120 ms showed a mortality 
of 20%; QRS between 120 and 160 ms, 36%; and above 160 
ms, the mortality was of 58%31. 
In our case selection, comparing the functional class and 
the QRS time length, a statistically significant difference was 
found between the groups in the pre-CRT period, where the 
group with QRS ≥ 160 ms showed a worse functional class31. 
In the 10-day follow-up period, there was no statistically 
significant difference between the two groups. In the two-year 
assessment, there was only one patient alive with QRS time 
length above 160 ms.
Many echocardiographic techniques have been used 
to quantify the interventricular and intraventricular 
dyssynchronies, with the purpose of optimizing the selection 
of patients for CRT.
The assessment of the interventricular dyssynchrony 
by using the M-mode of the echocardiogram (S/PW) was 
proposed by Pitzalis et al26 – in a group of 20 patients. All 
responders had an S/PW distance of more than 130 ms. 
In this test, we had a statistically significant reduction in 
the values of the S/PW value, when the three analysis periods 
were compared. However, there was no statistical difference 
in the death group compared to the non-death group in 
the pre-operation evaluation and in the 10-day follow-up 
period. In patients with ischemic cardiomyopathy, the S/PW 
variable analysis may be impaired by segmental contraction 
changes.
With the pulsed Doppler, Chung et al32 showed the link 
between this variable and the clinical improvement and 
reverse remodeling. 
In our group, there was a statistically significant difference 
in the pre-operation period and in the two post-operation 
evaluation periods. However, when we compared the values 
of the death group and non-death group, there was no 
statistically significant difference.
In the mitral regurgitation evaluation, in 10 days, 11 
patients showed no changes in the mitral regurgitation level. 
In the two-year follow-up period, 10 patients had the same 
level of regurgitation that they had in the pre-operation 
period in the first follow-up period (10 days) and subsequent 
worsening in the two-year assessment. In the comparison of 
the death-group and non-death group, the mitral insufficiency 
value was not statistically significant.
In a study with 85 patients, in a 6-month follow-up period 
after the CRT, Bax et al19 demonstrated the sensitiveness and 
specificity of 80% as a predictor of clinical improvement and 
92% of sensitiveness and specificity as a predictor of reverse 
remodeling, when the dyssynchrony value assessed by the 
tissue-Doppler was greater than 65 ms. 
In our group, we had a statistically significant difference 
in the variation of the tissue-Doppler of the pre-operation 
and post-operation periods. And, it was possible to consider 
that the tissue-Doppler evaluation in the first days after the 
procedure is a useful tool to assess the CRT’s efficiency. 
When compared to the death and non-death groups, the 
tissue-Doppler revealed an increase associated with the 
death group. 
 In this study, more advanced echocardiography techniques, 
such as the three-dimensional echocardiogram and the 
bidimensional strain, were not used. The use of such 
techniques, in the future, may expand the application of 
echocardiography in the evaluation of patients for CRT.
Study limitations
- Small case selection, with absence in the control group;
- Echocardiographic evaluation without intra and 
interobserver reproducibility study.
Conclusion
In the assessment of the echocardiographic parameters 
evaluated herein, only the intraventricular dyssynchrony 
through the tissue Doppler method after the procedure was 
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